Brief Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2010; 16(45): 5766-5772
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5766
Table 3 Clinical efficiency of refractory cases
Refractory casesTumor response evaluation1
Follow-up period (mo)Survival2
Target lesion4 2 mo post-TEATime to progress (mo)
1PR6.58.1No
2PR7.814.3Yes
3PR4.27.1No
4SD3.96.1No
5SD3.74.9No
6PR6.210.1No
7SD3.05.1No
8PR6.516.7Yes
9PR5.09.9No
10PD33.5No